Results 41 to 50 of about 2,785 (177)

Улипристала ацетат в лечении миомы матки: тенденции 2019 [PDF]

, 2019
ЖЕНСКИЕ БОЛЕЗНИМИОМА /ЛЕК ТЕРПРОТИВООПУХОЛЕВЫЕ СРЕДСТВА ГОРМОНАЛЬНЫЕ /ТЕР ПРИМРЕЦЕПТОРЫ ПРОГЕСТЕРОНА /ДЕЙСТВ ПРЕПУЛИПРИСТАЛА ...
Медведев, М. В., Покровенко, Д. А.   +1 more
core  

Ulipristal acetate determination using MBTH

International Journal of Research in Pharmaceutical Sciences, 2019
A simple visible spectrophotometric method is proposed for the determination of ulipristal acetate present in bulk and tablet formulation. The currently proposed method is established based on MBTH oxidation by ferric ions to form an active coupling species (electrophile), followed by its coupling with the ulipristal in acidic medium to form high ...
null Giri Prasad Gorumutchu, null Venkata Nadh Ratnakaram, null Kishore VNV   +2 more
openaire   +1 more source

ULIPRISTAL ACETATE VERSUS PLACEBO FOR FIBROID TREATMENT

International Journal of Advanced Research, 2023
Background: The efficacy and safety of oral ulipristal acetate for the treatment of symptomatic uterine fibroids before surgery are uncertain. Methods: We randomly assigned women with symptomatic fibroids, excessive uterine bleeding (a score of >100 on the pictorial blood-loss assessment chart [PBAC, an objective assessment of blood loss, in which ...
openaire   +1 more source

Magnetic resonance guided high intensity focused ultrasound (MR‐HIFU) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 6, Page 1172-1180, June 2025.
MR‐HIFU can offer rapid and sustainable symptom relief for selected symptomatic fibroid patients. The severity of fibroid‐related symptoms was significantly reduced at 3 and 12 months, while the quality of life had increased. In addition, the treatment can be offered to women planning future pregnancies, as no negative effect on future fertility or ...
Saara Otonkoski, Antti Viitala, Gaber Komar, Teija Sainio, Anna Yanovskiy, Roberto Blanco Sequieros, Antti Perheentupa, Kirsi Joronen   +7 more
wiley   +1 more source

Rapid and sensitive determination of selective progesterone modulator ulipristal acetate in human plasma [PDF]

, 2017
Ulipristal acetate is a new synthetic selective progesterone receptor modulator developed mainly as emergency contraceptive (EC) and also used for the treatment of uterine fibroids.
Datla, Peda Varma, Kodali, Balaji, Pappula, Nagaraju   +2 more
core   +1 more source

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding

Haemophilia, Volume 31, Issue 3, Page 485-493, May 2025.
ABSTRACT Introduction Heavy menstrual bleeding (HMB) is a common presenting symptom in women with bleeding disorders, yet haemostatic testing is sometimes overlooked, even when refractory HMB requires surgical intervention. Aim To determine the prevalence of bleeding disorders in women referred for surgical management of HMB and investigate screening ...
Alison Delaney, Evangelos I. Kritsotakis, Kevin Horner, Steve Kitchen, Jennifer Sedcole, Ted Baxter, Rhona M. Maclean, Michael Makris, Clare V. Samuelson   +8 more
wiley   +1 more source

Comparison between Mifepristone and Ulipristal acetate as an alternative to surgical management of uterine fibroids (Leiomyoma) in symptomatic patients of reproductive age group in Asian population [PDF]

, 2017
Background: Present study was a randomised prospective observational study carried out at Ashakiran Hospital and IVF centre Pune, Maharashtra, India to evaluate the efficacy, safety, and quality of life by using Ulipristal acetate 10 mg and Mifepristone ...
Kale, Ashish R.
core   +2 more sources

Establishment of a 3D spheroid culture system to evaluate the responsiveness of uterine leiomyoma cells to female hormones

Reproductive Medicine and Biology, Volume 24, Issue 1, January/December 2025.
Abstract Purpose Uterine leiomyomas (ULMs) are classified into those with and without MED12 mutations (MED12m(+) and MED12m(−), respectively). This study was undertaken to establish a culture system to evaluate the effect of female hormones on the growth of ULM cells in each ULM subtype.
Takahiro Sakai, Shun Sato, Tetsuro Tamehisa, Hitomi Takasaki, Takuya Kajimura, Isao Tamura, Norihiro Sugino   +6 more
wiley   +1 more source

Presenting risk information in sexual and reproductive health care [PDF]

, 2016
OBJECTIVES: Presenting risk information to patients is an important part of clinical encounters. Good risk communication improves patient satisfaction with their care and the decisions they make.
Akintomide, H, David, AL
core   +1 more source

The challenge of FIGO type 3 leiomyomas and infertility: Exploring therapeutic alternatives amidst limited scientific certainties

International Journal of Gynecology &Obstetrics, Volume 165, Issue 3, Page 975-987, June 2024.
Abstract Uterine leiomyomas (ULs) are non‐cancerous tumors composed of smooth muscle cells that develop within the myometrium and represent the most prevalent pathological condition affecting the female genital tract. Despite the volume of available research, many aspects of ULs remain unresolved, making it a “paradoxical disease” where the increase in
Alessandro Favilli, Ivan Mazzon, Andrea Etrusco, Miriam Dellino, Antonio Simone Laganà, Andrea Tinelli, Vito Chiantera, Ettore Cicinelli, Sandro Gerli, Amerigo Vitagliano   +9 more
wiley   +1 more source